A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis
- Resource Type
- Article
- Source
- In
Clinical Therapeutics 2007 29(9):2022-2030 - Subject
- Language
- ISSN
- 0149-2918